Evidence map›Paper›PMID 42782863›Full record

Observational studyCurrent oncology (Toronto, Ont.)2026

Expression VIII: Final Results of the Individual Perception and Level of Information of Patients with Borderline Tumors of the Ovary.

Sara Alavi-Demirci, Laura N Beckmann, Hannah Woopen, Clemens Liebrich, Yasemine Virk, Pauline Wimberger, Karol Kubiak, Anette Ligl-Löhner, Hans-Martin Enzinger, Vera Czolk and 10 more

Abstract readMulticenter StudyObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sara Alavi-DemirciCharité-University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gynecology, European Competence Center for Ovarian Cancer, 13353 Berlin, Germany.
Laura N BeckmannCharité-University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gynecology, European Competence Center for Ovarian Cancer, 13353 Berlin, Germany.
Hannah WoopenCharité-University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gynecology, European Competence Center for Ovarian Cancer, 13353 Berlin, Germany.ORCID 0000-0002-8617-5535
Clemens LiebrichDepartment of Obstetrics and Gynecology, Klinikum Wolfsburg, 38440 Wolfsburg, Germany.
Yasemine VirkNorth-Eastern German Society of Gynecological Oncology (NOGGO e.V.), 13359 Berlin, Germany.
Pauline WimbergerDepartment of Gynecology and Obstetrics, Medical Faculty, University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany.
Karol KubiakDepartment of Gynecology and Obstetrics, St. Franziskus Hospital Münster, 48145 Münster, Germany.
Anette Ligl-LöhnerDepartment of Gynecology and Obstetrics, Diakonissen-Stiftungs-Krankenhaus Speyer, 67346 Speyer, Germany.
Hans-Martin EnzingerDepartment of Gynecology, Frauenklinik am Klinikum am Bruderwald, Sozialstiftung Bamberg, 96049 Bamberg, Germany.
Vera CzolkDepartment of Gynecology and Obstetrics, Brüderklinikum Julia Lanz, 68163 Mannheim, Germany.
Georg KunzDepartment of Gynecology and Obstetrics, St. Johannes Hospital Dortmund, 44137 Dortmund, Germany.
Mandy ManglerDepartment for Obstetrics and Gynecology, Auguste-Viktora-Krankenhaus Vivantes, 12157 Berlin, Germany.
Tilmann LantzschDepartment of Gynecology, Hospital St. Elisabeth and St. Barbara, 06110 Halle (Saale), Germany.
Alexander MusteaDepartment of Gynaecology and Gynaecological Oncology, University Medical Center Bonn (UKB), 53127 Bonn, Germany.
Susanne FechnerGerman Ovarian Cancer Foundation, 13359 Berlin, Germany.
Aline BurdackDepartment of Gynecology and Obstetrics, Sana-Clinics Berlin Lichtenberg, 10365 Berlin, Germany.
Jürgen TerhaagDepartment of Gynecology and Obstetrics, Rottal Inn Kliniken, 84307 Eggenfelden, Germany.
Dorothea FischerDepartment of Obstetrics and Gynaecology, Ernst von Bergmann Clinic, 14467 Potsdam, Germany.
Cornelia MüllerDepartment of Gynaecology and Obstetrics, Brandenburg Medical School Theodor Fontane, University Clinic Brandenburg, 14770 Brandenburg an der Havel, Germany.
Jalid SehouliCharité-University Medical Center Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Gynecology, European Competence Center for Ovarian Cancer, 13353 Berlin, Germany.ORCID 0000-0002-5963-6623

Funding

Tesaro Bio Germany GmbH, Leopoldstraße 37A, 80802 München Unrestricted Grant
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Ovarian NeoplasmsAdultAgedFemaleGermanyHumansMiddle AgedSurveys and Questionnairesborderline tumordoctor–patient relationshipinformation needsovarian cancersurvey

Identifiers

PMID42782863
PMCPMC13605407

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.